Global Contraceptive Devices Market

Contraceptive Devices Market Size, Share, Growth Analysis, By Product(Condoms, Subdermal Implants, Contraceptive Drugs, Vaginal Rings), By End user(Male and Female) - Industry Forecast 2024-2031


Report ID: SQMIG35I2253 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 63 | Figures: 75

Contraceptive Devices Market Insights

Global Contraceptive Devices Market size was valued at USD 26.68 billion in 2021 and is poised to grow from USD 28.3 billion in 2022 to USD 45.31 billion by 2030, growing at a CAGR of 6.06% during the forecast period (2023-2030).

To foster market growth, programs focused on reducing unintended pregnancies and associated healthcare costs and enhancing user awareness are anticipated. Numerous initiatives, such as Every Woman Every Child, Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning, have been launched by governments and healthcare organizations to promote family planning and the manufacturing and utilization of contraceptives. Private and public sectors both play significant roles as providers of contraceptives. The private sector primarily supplies short-acting resupply contraceptive methods like condoms and contraceptive pills, consistently holding a considerable market share. In Asia, for instance, around 41% of females obtain contraceptives from private-sector sources, while approximately 56% rely on public sources. Across 36 evaluated countries categorized as low- and middle-income, about 63% of women acquire contraceptives from the private sector, whereas approximately 34% utilize public-sector sources.

Governments worldwide are actively engaged in comprehensive campaigns and sex education programs targeting youth to raise awareness and promote the use of contraceptives to prevent STDs and unintended pregnancies. Esteemed healthcare organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are pivotal in disseminating knowledge about safe sex practices, including the importance of condom usage.

Market snapshot - 2024-2031

Global Market Size

USD 26.68 billion

Largest Segment

Male

Fastest Growth

Male

Growth Rate

6.06% CAGR

Global Contraceptive Devices Market ($ Bn)
Country Share for North America Region (%)
Global Contraceptive Devices Market By End User ($ Bn)
Global Contraceptive Devices Market By End User(%)

To get more reports on the above market click here to Buy The Report

Contraceptive Devices Market Segmental Analysis

Global Contraceptive Devices Market is segmented by product, end user, and region. Based on Product, the market can be segmented into condoms, subdermal implants, contraceptive drugs, vaginal rings, and diaphragms. Based on End user, the market is segmented into male and female. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Analysis by Product

By Product, the market can be segmented into condoms, subdermal implants, contraceptive drugs, vaginal rings, and diaphragms. Condoms segment is the dominating segment in the market. It held the largest share in 2023. This is also due to the rise in demand from the public sector. It was reported in 2023 that, around 378.1 million units of condoms were supplied by the Department of Health & Family Welfare in India.

The contraceptive drugs segment is expected to experience significant growth and is the fastest-growing segment. The segment includes progestin-only pills and combination hormonal contraceptives.

Analysis by End user

By end user, the market can be segmented into males and females. The male represents the dominating segment in the Contraceptive Devices market. There is a growing awareness and acceptance of male contraception as a shared responsibility between partners. Male contraceptive methods, such as condoms and vasectomy, offer effective options for family planning. Additionally, advancements in male contraceptive research and development are expanding the range of available options.

The female segment has emerged as the fastest-growing segment in the Contraceptive Devices market. Female contraceptive devices such as intrauterine devices (IUDs), hormonal implants, and birth control pills are widely used to prevent unwanted pregnancies.

Global Contraceptive Devices Market By End User, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Contraceptive Devices Market Regional Insights

North America dominated the global Contraceptive Devices market. It holds a maximum revenue share of more than 32.90%. The region's high rates of abortion, growing population of women between the ages of 15 and 44, and high patient awareness levels during the predicted period. Teenagers' desire for contraceptives has increased because of the introduction of generic and inexpensive medications and technologies.

Asia Pacific is expected to be the fastest growing region in the global Contraceptive Devices market. The rapid rise in this region is explained by an increase in governmental activities, a rise in population control demands, and a decline in the prevalence of unplanned pregnancies. The Centre for Reproductive Rights estimates that every year in Asia, there are about 53.8 million unwanted pregnancies, with about 65% of them ending in abortions. In Asia, the prevalence of contraception among married teens is roughly 41%.

Global Contraceptive Devices Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Contraceptive Devices Market Dynamics

Drivers

Development of a highly efficient

  • One groundbreaking advancement in contraceptive technology is the development of a highly efficient, non-hormonal intrauterine device (IUD). This innovative device offers women a reliable and long-lasting method of birth control. By utilizing a unique design that promotes both safety and ease of use, this IUD provides a hassle-free contraceptive solution while minimizing potential side effects. It’s effectiveness and user-friendly nature make it a promising option for women seeking convenient and reliable contraception.

Restraints

Increasing risk of infections regarding the use of contraceptive devices

  • Contraceptive devices empower individuals to make informed choices about their reproductive health. By providing a reliable and accessible method of birth control, these devices promote reproductive autonomy and enable individuals to plan their families according to their personal circumstances. With a wide range of options available, including condoms, intrauterine devices (IUDs), and hormonal implants, contraceptive devices offer diverse choices to suit individual needs, fostering responsible sexual practices and reducing the risk of unintended pregnancies. Their availability promotes safer and healthier sexual experiences, ultimately empowering individuals to control their own reproductive journeys.

Request Free Customization of this report to help us to meet your business objectives.

Contraceptive Devices Market Competitive Landscape

global contraceptive devices market features a highly competitive landscape with the presence of several key players. These companies focus on innovation, product development, strategic partnerships, and mergers and acquisitions to gain a competitive edge in the market. These key players, along with several other regional and local manufacturers, form a highly competitive landscape in the global market. Constant research and development, product diversification, and strategic partnerships remain crucial for companies to sustain growth and maintain a competitive advantage.

Top Player’s Company Profiles

  • Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Merck Sharp & Dohme Corp. (US)
  • Mylan N.V. (US)
  • Reckitt Benckiser Group plc. (UK)
  • Veru Inc. (US)
  • Medisafe Distribution Inc. (Canada)
  • CooperSurgical, Inc. (US)
  • Devex (US)
  • Mayer Laboratories, Inc. (US)
  • Allergan plc (Ireland)
  • Agile Therapeutics (US)
  • HLL Lifecare (India)
  • ANSELL LTD (Australia)
  • Mankind Pharma (India)
  • TTK HealthCare (India)
  • Boehringer Ingelheim International GmbH. (Austria)
  • V-Care Pharma Pvt. Ltd. (India)

Recent Developments

  • In April 2022, after receiving funding from the Bill and Melinda Gates Foundation, ProMed Pharma started the preclinical assessment of a brand-new, totally resorbable contraceptive implant.
  • In July 2021, after contacting a pharmacist, progestogen-only contraceptive pills will be sold over the counter at pharmacies without a prescription, according to the Medicines and Healthcare Products Regulatory Agency (MHRA).
  • In January 2021, Teva Pharmaceuticals has made the generic version of the vaginal ring NuvaRing (etonogestrel and ethinyl estradiol) available in the United States. These vaginal rings have been introduced, and it is anticipated that the market for vaginal rings as contraceptive methods will grow.

Contraceptive Devices Key Market Trends

  • The market is being driven by a number of factors, such as rising unwanted pregnancy rates and increased understanding and use of family planning techniques. Additionally, the soaring prevalence of STIs and the increased government financing for family planning programmes are promoting market expansion. The availability of numerous contraceptive methods, such as condoms, intrauterine devices, oral contraceptives, and subdermal implants, as well as rising consumer spending power, are also contributing to the market's expansion. In addition, the rise of the e-commerce industry, the development of long-acting reversible contraceptives, and the escalating trend of product innovations are boosting the market. This is in accordance with the growing demand for non-hormonal and natural contraceptives and the rising popularity of female-controlled contraceptive techniques, both of which are fostering market expansion.

Contraceptive Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global contraceptive device market analysis, the market is witnessing substantial growth driven by factors such as the unmet demand for contraception among women and the prevalence of sexually transmitted diseases (STDs). With around 1.1 billion reproductive-age women globally requiring family planning, initiatives like Every Woman Every Child, Millennium Development Goals, and Family Planning 2021 are promoting the use of contraceptives. Both the private and public sectors play significant roles in providing contraceptive devices, with the private sector primarily offering short-acting methods like condoms and pills. Governments and healthcare organizations are actively conducting campaigns and sex education programs to raise awareness among youth and promote contraceptive usage. Esteemed healthcare organizations such as the World Health Organization and the Centers for Disease Control and Prevention are crucial in disseminating knowledge about safe sex practices. Overall, the market growth is fueled by the demand for family planning, the need to address STDs, and the collective efforts of stakeholders to enhance contraceptive accessibility and awareness.

Report Metric Details
Market size value in 2023 USD 26.68 billion
Market size value in 2031 USD 45.31 billion
Growth Rate 6.06%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Condoms, Subdermal Implants, Contraceptive Drugs, Vaginal Rings, and Diaphragms
  • End user
    • Male and Female
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Merck Sharp & Dohme Corp. (US)
  • Mylan N.V. (US)
  • Reckitt Benckiser Group plc. (UK)
  • Veru Inc. (US)
  • Medisafe Distribution Inc. (Canada)
  • CooperSurgical, Inc. (US)
  • Devex (US)
  • Mayer Laboratories, Inc. (US)
  • Allergan plc (Ireland)
  • Agile Therapeutics (US)
  • HLL Lifecare (India)
  • ANSELL LTD (Australia)
  • Mankind Pharma (India)
  • TTK HealthCare (India)
  • Boehringer Ingelheim International GmbH. (Austria)
  • V-Care Pharma Pvt. Ltd. (India)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Contraceptive Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Contraceptive Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Contraceptive Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Contraceptive Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Contraceptive Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Contraceptive Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Contraceptive Devices Market size was valued at USD 26.68 billion in 2021 and is poised to grow from USD 28.3 billion in 2022 to USD 45.31 billion by 2030, growing at a CAGR of 6.06% during the forecast period (2023-2030).

contraceptive devices market features a highly competitive landscape with the presence of several key players. These companies focus on innovation, product development, strategic partnerships, and mergers and acquisitions to gain a competitive edge in the market. These key players, along with several other regional and local manufacturers, form a highly competitive landscape in the market. Constant research and development, product diversification, and strategic partnerships remain crucial for companies to sustain growth and maintain a competitive advantage. 'Bayer AG (Germany)', 'Pfizer Inc. (US)', 'Janssen Services, LLC (US)', 'Teva Pharmaceutical Industries Ltd. (Jerusalem)', 'Merck Sharp & Dohme Corp. (US)', 'Mylan N.V. (US)', 'Reckitt Benckiser Group plc. (UK)', 'Veru Inc. (US)', 'Medisafe Distribution Inc. (Canada)', 'CooperSurgical, Inc. (US)', 'Devex (US)', 'Mayer Laboratories, Inc. (US)', 'Allergan plc (Ireland)', 'Agile Therapeutics (US)', 'HLL Lifecare (India)', 'ANSELL LTD (Australia)', 'Mankind Pharma (India)', 'TTK HealthCare (India)', 'Boehringer Ingelheim International GmbH. (Austria)', 'V-Care Pharma Pvt. Ltd. (India)'

One groundbreaking advancement in contraceptive technology is the development of a highly efficient, non-hormonal intrauterine device (IUD). This innovative device offers women a reliable and long-lasting method of birth control. By utilizing a unique design that promotes both safety and ease of use, this IUD provides a hassle-free contraceptive solution while minimizing potential side effects. It’s effectiveness and user-friendly nature make it a promising option for women seeking convenient and reliable contraception.

The market is being driven by a number of factors, such as rising unwanted pregnancy rates and increased understanding and use of family planning techniques. Additionally, the soaring prevalence of STIs and the increased government financing for family planning programmes are promoting market expansion. The availability of numerous contraceptive methods, such as condoms, intrauterine devices, oral contraceptives, and subdermal implants, as well as rising consumer spending power, are also contributing to the market's expansion. In addition, the rise of the e-commerce industry, the development of long-acting reversible contraceptives, and the escalating trend of product innovations are boosting the market. This is in accordance with the growing demand for non-hormonal and natural contraceptives and the rising popularity of female-controlled contraceptive techniques, both of which are fostering market expansion.

North America dominated the Contraceptive Devices market. It holds a maximum revenue share of more than 32.90%. The region's high rates of abortion, growing population of women between the ages of 15 and 44, and high patient awareness levels during the predicted period. Teenagers' desire for contraceptives has increased because of the introduction of generic and inexpensive medications and technologies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Contraceptive Devices Market

Product ID: SQMIG35I2253

$5,300
BUY NOW GET FREE SAMPLE